- Home
- TREO vs PAVM Comparison
TREO vs PAVM Comparison
Compare TREO & PAVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TREO | PAVM |
|---|---|---|
| Founded | N/A | 2014 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Metal Mining | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.9M | 41.1M |
| IPO Year | N/A | 2015 |
Fundamental Metrics
Financial Performance| Metric | TREO | PAVM |
|---|---|---|
| Price | $2.02 | $2.53 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $36.50 |
| AVG Volume (30 Days) | ★ 40.4K | 20.6K |
| Earning Date | 11-06-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $3,000,000.00 |
| Revenue This Year | N/A | $132.39 |
| Revenue Next Year | N/A | $263.64 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 20.00 |
| 52 Week Low | $2.05 | $0.21 |
| 52 Week High | $5.90 | $52.90 |
Technical Indicators
Market Signals| Indicator | TREO | PAVM |
|---|---|---|
| Relative Strength Index (RSI) | 22.41 | 25.97 |
| Support Level | N/A | N/A |
| Resistance Level | $3.50 | $6.56 |
| Average True Range (ATR) | 0.41 | 0.30 |
| MACD | -0.05 | -0.04 |
| Stochastic Oscillator | 0.87 | 6.81 |
Price Performance
Historical ComparisonAbout TREO Tactical Resources Corp. Common Shares
Tactical Resources Corp is an exploration & development company focused on the rare earth elements (REE) that drive the green technologies of the future. Its projects include Lac Ducharme Project, Sierra Blanca Quarry Project, and Peak Project.
About PAVM PAVmed Inc.
PAVmed Inc is a multi-product, commercial-stage medical technology company organized to advance a broad pipeline of medical technologies from concept to commercialization. The company operates in a single segment as a medical technology company, with the following lines of business: Diagnostics, Medical Devices, and Digital Health. Its products are EsoGuard, EsoCheck, and the Veris Cancer Care Platform.